Page-5 of Pharma sector
Lupin acquires US pharmaceutical firm Gavis
Indian pharmaceutical major Lupin has acquired US based Gavis Pharmaceuticals in cash-free and debt-free transaction for 880 million dollars (around 5,606 crore rupees). In this regard, Lupin has entered into definite agreement with Gavis Pharmaceuticals LLC and its subsidiary Novel ..
Month: Current Affairs - July, 2015
Union Government brings 39 more Pharmaceutical drugs under price control
Union government has brought 39 more Pharmaceutical drugs under price control as part of its efforts to make medicines affordable in the country. The drugs brought under this price control regime include the durgs which can be used to treat ..
Month: Current Affairs - July, 2015
Union Government scraps import duties on AIDS drugs and test kits
Union Government has scrapped customs import duties for drugs and test kits used to treat Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS). In this regard Central Board of Excise and Customs (CBEC) has issued a notice that ..
Month: Current Affairs - June, 2015
India, Netherlands sign MoU for development of Measles- Rubella Vaccines
India and Netherlands have signed a Memorandum of Understanding (MoU) for the development of Measles- Rubella Vaccines. The MoU was signed under Make in India initiative of Union government in the presence of the Netherlands Prime Minister Mark Rutte during ..
Month: Current Affairs - June, 2015
India fourth largest supplier of generic medicines to US: Government
India has emerged as the fourth largest supplier of generic medicines to the United States. It was announced by Minister of State (MoS) for Chemicals and Fertilizers Hansraj Ahir gave this information in the Rajya Sabha in reply to a ..
Month: Current Affairs - April, 2015
Union Government allows pharmaceutical companies to hike rates of 509 essential medicines
Union government has allowed pharmaceutical companies to hike rates of 509 essential medicines by 3.84 per cent. The new prices will be effective from 1 April 2015. In this regard, National Pharmaceutical Pricing Authority (NPPA) has issued a notification under ..